Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the...
The key influencers of trends are the fundamental factors driving the underlying financial asset and market sentiment.
As an example of fundamental factors, the price development of a share can be a reflection of the company's economic strength.
Accordingly, a price increase may be due to the company's success in implementing its business plan or to the...
$SMMT insider ownership is crazy high and the CEO owns 162+ Mil shares by himself, that’s crazy confidence!
Insider Ownership 82%
cdn.discordapp.com
media.discordapp.net
www.sec.gov
NASDAQ:SMMT
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that...
Breaking Key area, and Also major resistance and can go back to down side to the consolidation zone. signs look bullish, but a key area to watch.
Have a Happy Day
Reversal on the 4 hour, from a huge drop in Dec due to poor results for their trials when they combined data. They said 2022 end of 1st quarter they will release an update. They stopped the offering to investors and will give an update later.
This may be catching a falling knife, but I found SMMT on my scanner after it was down 50% in a day
If you look at all the analyst ratings on this stock there's no reason it should be down where it is right now.
It's down to $2.44 right now at it's 52 week low when just weeks ago it was worth $12 a share.
This is a bargain, it's fallen hard before but there's good...
Contextual immersion trading strategy idea.
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the...
Contextual immersion trading strategy idea.
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the...
There was a suggestion that the pharmaceutical outsourcing in America is coming back to America so there is 90% up for grabs and they have a good opportunity, also looks like a hammer on the one amateur one hour chart , I could just be hopeful do not copy but feel free to comment .
